Patents by Inventor Stephen Hill

Stephen Hill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10244230
    Abstract: The present disclosure relates to a directional pixel for a high-angular resolution, wide field of view, multiple view display. The design teaches a directional pixel comprising a substrate, one or more pixel driving circuits, one or more nano- or micro-scale subpixels, and one or more directional optical guiding surfaces, wherein each of said one or more subpixels is comprised of a light emitting device emitting a light beam and an optical microcavity housing said light emitting device. The optical microcavity is comprised of a plurality of reflective surfaces to specifically manipulate and tune said light beam, wherein one or more of said reflective surfaces is a light propagating reflective surface which propagates said light beam out of said microcavity, and said light propagating reflective surface is connected to said one or more directional optical guiding surfaces to direct said light beam at a specific angle.
    Type: Grant
    Filed: March 1, 2017
    Date of Patent: March 26, 2019
    Assignee: Avalon Holographics Inc.
    Inventors: Wally Haas, Jennifer Campbell-Correa, Matthew Hamilton, Stephen Hill, Jordan Peckham, Chuck Rumbolt
  • Patent number: 10172826
    Abstract: A dietary supplement composition is formulated in a therapeutic amount to treat and alleviate symptoms of hot flashes in a female subject, such as experiencing symptoms of perimenopause. The composition includes a phytoestrogen and lycopene in an oral dosage form. The phytoestrogen may include a plant lignan including at least one of Matairesinol, 7-hydroxymatairesinol, Secoisolariciresinol, Lariciresinol and Pinoresinol. The lycopene may include a lycopene complex having at least one of phytoene, phytofluene, beta-carotene, tocopherols and phytosterols.
    Type: Grant
    Filed: May 1, 2017
    Date of Patent: January 8, 2019
    Assignee: U.S. NUTRACEUTICALS, LLC
    Inventors: John A. Minatelli, W. Stephen Hill, Rudi E. Moerck, Jessica Engle
  • Publication number: 20180314798
    Abstract: A system and a method for directing medical patients to an appropriate level of care and processes for directing a medical patient to an appropriate healthcare resource are disclosed. The system, the method, and the processes allow non-physicians to navigate the healthcare system, prevent missed emergencies, and direct patients to appropriate healthcare resources, thereby making healthcare more affordable, accessible, and efficient.
    Type: Application
    Filed: December 29, 2016
    Publication date: November 1, 2018
    Inventors: CALEB SANTIAGO HERNANDEZ, MICHAEL STEPHEN HILL
  • Publication number: 20180289735
    Abstract: A dietary supplement composition is formulated in a therapeutic amount to treat and alleviate symptoms of joint pain in an animal such as a human patient or non-human animal. The dietary supplement composition comprises hyaluronic acid/hyaluronan, which includes pro-inflammatory low molecular weight sodium hyaluronate fragments having a molecular weight of 0.5 to 300 kilodaltons (kDa) in an oral dosage form. The hyaluronic acid/hyaluronan also includes hyaluronic acid/hyaluronan having a molecular weight greater than the 0.5 to 300 kDa range. The composition may include eggshell membrane.
    Type: Application
    Filed: May 24, 2018
    Publication date: October 11, 2018
    Inventors: W. STEPHEN HILL, PATRICIA M. O'CONNELL, UMASUDHAN C. PALANISWAMY
  • Publication number: 20180280450
    Abstract: The present invention relates to compositions and methods for promoting the immune health of an animal or human by administering compositions or mixtures of water-soluble components derived from a genus Euglena organism that are capable of stimulating immune system activity in the absence of beta-glucan.
    Type: Application
    Filed: March 28, 2018
    Publication date: October 4, 2018
    Inventors: Robert Bernard LEVINE, Geoffrey Paul HORST, John A. MINATELLI, W. Stephen HILL, Patricia M. O'CONNELL
  • Publication number: 20180255286
    Abstract: The present disclosure relates to a directional pixel for a high-angular resolution, wide field of view, multiple view display. The design teaches a directional pixel comprising a substrate, one or more pixel driving circuits, one or more nano- or micro-scale subpixels, and one or more directional optical guiding surfaces, wherein each of said one or more subpixels is comprised of a light emitting device emitting a light beam and an optical microcavity housing said light emitting device. The optical microcavity is comprised of a plurality of reflective surfaces to specifically manipulate and tune said light beam, wherein one or more of said reflective surfaces is a light propagating reflective surface which propagates said light beam out of said microcavity, and said light propagating reflective surface is connected to said one or more directional optical guiding surfaces to direct said light beam at a specific angle.
    Type: Application
    Filed: March 1, 2017
    Publication date: September 6, 2018
    Inventors: Wally Haas, Jennifer Campbell-Correa, Matthew Hamilton, Stephen Hill, Jordan Peckham, Chuck Rumbolt
  • Publication number: 20180250326
    Abstract: A dietary supplement composition is formulated in a therapeutic amount to treat and alleviate symptoms of joint pain. The composition includes pro-inflammatory low molecular weight microbial fermented sodium hyaluronate fragments having a molecular weight of 0.5 to 300 kilodaltons (kDa) in an oral dosage form.
    Type: Application
    Filed: May 3, 2018
    Publication date: September 6, 2018
    Inventors: John A. Minatelli, W. Stephen Hill, Rudi E. Moerck
  • Patent number: 9999631
    Abstract: A dietary supplement composition is formulated in a therapeutic amount to treat and alleviate symptoms of joint pain. The composition includes pro-inflammatory low molecular weight microbial fermented sodium hyaluronate fragments having a molecular weight of 0.5 to 300 kilodaltons (kDa) in an oral dosage form.
    Type: Grant
    Filed: June 28, 2016
    Date of Patent: June 19, 2018
    Assignee: U.S. NUTRACEUTICALS, LLC
    Inventors: John A. Minatelli, W. Stephen Hill, Rudi E. Moerck
  • Patent number: 9974756
    Abstract: A dietary supplement composition and associated method of use has the composition formulated in a therapeutic amount to treat and alleviate symptoms of joint pain in a person having joint pain. The composition includes astaxanthin and microbial fermented, low molecular weight hyaluronic acid or sodium hyaluronate (hyaluronan). The composition also includes at least one of a phospholipid, glycolipid, and sphingolipid. It is formulated into an oral dosage form and the astaxanthin is 0.1 to 15 percent by weight of the at least one phospholipid, glycolipid, and sphingolipid.
    Type: Grant
    Filed: September 21, 2016
    Date of Patent: May 22, 2018
    Assignee: U.S. NUTRACEUTICALS, LLC
    Inventors: John A. Minatelli, W. Stephen Hill, Rudi E. Moerck
  • Patent number: 9913810
    Abstract: A dietary supplement composition and associated method of use has the composition formulated in a therapeutic amount to treat and alleviate symptoms of joint pain in a person having joint pain. The composition includes astaxanthin and microbial fermented, low molecular weight hyaluronic acid or sodium hyaluronate (hyaluronan). The composition also includes at least one of a phospholipid, glycolipid, and sphingolipid. It is formulated into an oral dosage form and the astaxanthin is 0.1 to 15 percent by weight of the at least one phospholipid, glycolipid, and sphingolipid.
    Type: Grant
    Filed: March 12, 2015
    Date of Patent: March 13, 2018
    Assignee: U.S. NUTRACEUTICALS, LLC
    Inventors: John A. Minatelli, W. Stephen Hill, Rudi E. Moerck
  • Publication number: 20180042978
    Abstract: A method of treating photo-induced ocular fatigue and associated reduction in speed of ocular focus in humans includes administering a therapeutic amount of a dietary supplement composition comprising a carrier admixed with carotenoids, which may include 0.5 to 8.0 mg of astaxanthin, 2.0 to 15 mg of lutein and 0.2 to 12.0 mg of zeaxanthin. The composition is formulated into an oral dosage form as a single dosage capsule.
    Type: Application
    Filed: October 23, 2017
    Publication date: February 15, 2018
    Inventors: JOHN A. MINATELLI, W. STEPHEN HILL
  • Patent number: 9795631
    Abstract: A dietary supplement composition is formulated in a therapeutic amount to treat and alleviate symptoms of joint pain. The composition includes pro-inflammatory low molecular weight microbial fermented sodium hyaluronate fragments having a molecular weight of 0.5 to 300 kilodaltons (kDa) and astaxanthin in an oral dosage form. The astaxanthin may be derived from a natural or synthetic ester or synthetic diol. The composition may include a mixture of cartilage and salt and boron.
    Type: Grant
    Filed: June 27, 2016
    Date of Patent: October 24, 2017
    Assignee: U.S. NUTRACEUTICALS, LLC
    Inventors: John A. Minatelli, W. Stephen Hill, Rudi E. Moerck
  • Patent number: 9800489
    Abstract: Technology for auditing monitors is provided. In one example, a method may include identifying a virtualized computing system to be audited. The method may further include identifying existing monitors on the virtualized computing system for monitoring the virtualized computing system and collecting metrics. The existing monitors may be compared against defined monitors specified in a data store for the virtualized computing system to identify missing monitors absent from the virtualized computing system. The virtualized computing system having the missing monitors may be flagged.
    Type: Grant
    Filed: December 17, 2014
    Date of Patent: October 24, 2017
    Assignee: Amazon Technologies, Inc.
    Inventors: Ruslan Anatolyevich Polyanskiy, Sangkyun Yoon, Colby Jordan, Volodymyr Nikitinskyy, Bernard L Griesmer, Sukhreet Kaur Buttar, Loren Stephen Hills
  • Publication number: 20170281564
    Abstract: A dietary supplement includes comprising a therapeutic amount of astaxanthin derived from a synthetic or natural ester or diol, and at least one of a phospholipid, glycolipid, and sphingolipid, and formulated into an oral dosage form, wherein the astaxanthin is 0.1 to 15 percent by weight of the at least one phospholipid, glycolipid, and sphingolipid. The composition includes 0.5 to 12 mg of astaxanthin and may be used to treat low density lipoprotein (LDL) oxidation in humans and other diseases, disorders and impairments.
    Type: Application
    Filed: June 7, 2017
    Publication date: October 5, 2017
    Inventors: John A. MINATELLI, W. Stephen Hill, Rudi E. Moerck
  • Patent number: 9770047
    Abstract: A composition of matter comprises a shelf stable, partially defatted supercritical CO2 fluid solvent extracted whole grain flour derived from a cracked biomass of perilla frutescens, the flour comprising minerals and 2 to 8 percent of native seed oil, 35 to 45 percent protein, and 35 to 45 percent fiber.
    Type: Grant
    Filed: June 5, 2013
    Date of Patent: September 26, 2017
    Assignee: U.S. NUTRACEUTICALS, LLC
    Inventors: John A. Minatelli, W. Stephen Hill, Rudi E. Moerck, Uy Nguyen
  • Patent number: 9763897
    Abstract: A dietary supplement includes comprising a therapeutic amount of astaxanthin derived from a synthetic or natural ester or diol, and at least one of a phospholipid, glycolipid, and sphingolipid, and formulated into an oral dosage form, wherein the astaxanthin is 0.1 to 15 percent by weight of the at least one phospholipid, glycolipid, and sphingolipid. The composition includes 0.5 to 12 mg of astaxanthin and may be used to treat low density lipoprotein (LDL) oxidation in humans and other diseases, disorders and impairments.
    Type: Grant
    Filed: March 16, 2015
    Date of Patent: September 19, 2017
    Assignee: U.S. NUTRACEUTICALS, LLC
    Inventors: John A. Minatelli, W. Stephen Hill, Rudi E. Moerck
  • Publication number: 20170232034
    Abstract: A dietary supplement composition is formulated in a therapeutic amount to treat and alleviate symptoms of joint pain. The composition includes pro-inflammatory low molecular weight microbial fermented sodium hyaluronate fragments and glucosamine in an oral dosage form.
    Type: Application
    Filed: May 3, 2017
    Publication date: August 17, 2017
    Inventors: JOHN A. MINATELLI, W. STEPHEN HILL, RUDI E. MOERCK
  • Publication number: 20170231950
    Abstract: A dietary supplement composition is formulated in a therapeutic amount to treat and alleviate symptoms of hot flashes in a female subject, such as experiencing symptoms of perimenopause. The composition includes a phytoestrogen and lycopene in an oral dosage form. The phytoestrogen may include a plant lignan including at least one of Matairesinol, 7-hydroxymatairesinol, Secoisolariciresinol, Lariciresinol and Pinoresinol. The lycopene may include a lycopene complex having at least one of phytoene, phytofluene, beta-carotene, tocopherols and phytosterols.
    Type: Application
    Filed: May 1, 2017
    Publication date: August 17, 2017
    Inventors: JOHN A. MINATELLI, W. STEPHEN HILL, RUDI E. MOERCK, JESSICA ENGLE
  • Publication number: 20170216383
    Abstract: In accordance with a non-limiting example, an algae based oil is used in place of a krill oil to treat low density lipoprotein (LDL) oxidation in humans by administering a therapeutic amount of a dietary supplement composition comprising an algae based oil comprising glycolipids and phospholipids and Eicosapentaenoic (EPA) fatty acids in combination with astaxanthin derived from Haematococcus pluvialis (Hp) in an oral dosage form, wherein the astaxanthin derived from Haematococcus pluvialis (Hp) is 0.1 to 4.0 percent by weight of the algae based oil.
    Type: Application
    Filed: April 20, 2017
    Publication date: August 3, 2017
    Inventors: John A. MINATELLI, W. STEPHEN HILL, RUDI E. MOERCK
  • Patent number: 9675635
    Abstract: A dietary supplement composition is formulated in a therapeutic amount to treat and alleviate symptoms of joint pain. The composition includes pro-inflammatory low molecular weight microbial fermented sodium hyaluronate fragments and glucosamine in an oral dosage form.
    Type: Grant
    Filed: June 10, 2015
    Date of Patent: June 13, 2017
    Assignee: U.S. NUTRACEUTICALS, LLC
    Inventors: John A. Minatelli, W. Stephen Hill, Rudi E. Moerck